Skip to search formSkip to main contentSkip to account menu

T 3762

Known as: T-3762 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Fluoroquinolones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Effect of pazufloxacin mesilate on the serum concentration of theophylline
Abstract We studied the effect of pazufloxacin mesilate (T-3762), a new fluoroquinolone for intravenous administration, on the… 
Review
2000
Review
2000
Pazufloxacin Toyama Chemical Co.
Toyama Chemical Co Ltd is developing pazufloxacin (T-3761), an orally active synthetic quinolone antibiotic, which is awaiting… 
1999
1999
In vitro Activities of Pazufloxacin,a Novel In jectable Quinolone, against Bacteria Causing Infections in Obstetric and Gynecological Patients
T-3762 is an injectable new quinolone with a broad spectrum of antibacterial activity. Pazufloxacin (T-3761) is an active form of… 
1998
1998
Histamine-releasing properties of T-3762, a novel fluoroquinolone antimicrobial agent in intravenous use. I. Effects of doses and infusion rate on blood pressure, heart rate and plasma histamine…
T-3762, a newly developed fluoroquinolone antimicrobial agent, ciprofloxacin (CPFX) and ofloxacin (OFLX) were administered… 
1998
1998
Histamine-releasing properties of T-3762, a novel fluoroquinolone antimicrobial agent in intravenous use. II. Dermovascular permeability-increasing effect and action on peritoneal mast cells.
To predict the actions of T-3762, a newly developed fluoroquinolone antimicrobial agent, as well as ciprofloxacin (CPFX) and… 
1998
1998
[Reproductive and developmental toxicity study of T-3762 in rats administered intravenously during the period of organogenesis].
A teratogenicity study of T-3762, an injectable new quinolone antibacterial agent, was conducted in Sprague-Dawley rats to… 
1998
1998
Pharmacological properties of T-3762, a novel fluoroquinolone antimicrobial agent in parenteral use. III. Chemical structures and dermovascular permeability-increasing activities.
Fluoroquinolone antibiotics and chemically related compounds including the pazufloxacin methanesulfonate named T-3762 were… 
1998
1998
[Single dose intravenous toxicity studies of T-3762, a novel parenteral quinolone antimicrobial agent, in rats, dogs and monkeys].
Single dose intravenous toxicity studies of T-3762, a novel parenteral quinolone antimicrobial agent, were conducted in rats… 
1998
1998
[Three months intravenous repeated dose toxicity study of T-3762 in rats].
A three months intravenous repeated dose toxicity study of T-3762, a novel parenteral quinolone antibacterial agent, was carried… 
1995
1995
Bactericidal activity of parenteral fluoroquinolone T-3762 against Pseudomonas aeruginosa and Escherichia coli.
A high concentration of parenteral fluoroquinolone, T-3762 was used to study its antimicrobial activity against Pseudomonas… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)